NCT07876232 Comparison of Surgical Techniques for Anterior Shoulder Instability
| NCT ID | NCT07876232 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riga Stradins University |
| Condition | Surgeons |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-11-01 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Study objectives Primary Objective To compare the clinical and functional outcomes of arthroscopic Bankart repair and Dynamic Anterior Stabilization (DAS) in patients with chronic anterior shoulder instability and subcritical glenoid bone loss (10-20%). Secondary Objectives To evaluate postoperative shoulder stability, recurrence of instability, functional outcomes, complications, and return to daily and sports activities following the two surgical techniques. To assess the relationship between the extent of glenoid bone loss and postoperative clinical and functional outcomes. To identify clinical and morphological factors associated with postoperative outcomes and recurrence of anterior shoulder instability. We evaluate every patient at 1 month, 3 months, 6 months, 12 months, and 24 months. For evaluation, the Constant Shoulder Score, ASES Score, Visual Analog pain scale, and Oxford instability score
Eligibility Criteria
Inclusion Criteria: * Patients aged ≤50 years; * History of anterior shoulder dislocation and/or subluxation; * Persistent anterior glenohumeral instability; * MRI-confirmed anterior labral injury and Hill-Sachs lesion; * CT-confirmed glenoid bone loss of 10-20% of the total glenoid articular surface. Exclusion Criteria: * Patients aged \>50 years; * Concomitant injuries or pathological conditions involving other structures of the shoulder joint; * Multidirectional shoulder instability; * Previous surgical procedures on the affected shoulder; * Acute infection; * Coagulation disorders; * Systemic diseases, including diabetes mellitus (DM), rheumatoid arthritis (RA), gout, and autoimmune diseases (AIDs).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07876232 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Surgeons. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07876232 currently recruiting?
Yes, NCT07876232 is actively recruiting participants. Contact the research team at andrejs.finogejevs@inbox.lv for enrollment information.
Where is the NCT07876232 trial being conducted?
This trial is being conducted at Riga, Latvia.
Who is sponsoring the NCT07876232 clinical trial?
NCT07876232 is sponsored by Riga Stradins University. The trial plans to enroll 60 participants.